2020 American Society of Hematology Virtual Annual Meeting*

Expert faculty review and share their insights and perspectives on key studies on the management of acute and chronic leukemias presented at the virtual Hematology 2020 annual meeting.

Jorge Cortes, MD Eunice S. Wang, MD Physicians: maximum of 1.25 AMA PRA Category 1 Credits™ Released: February 12, 2021 Expired: No longer available for credit

In this commentary, 2 experts discuss their top presentation choices from ASH 2020 in acute and chronic leukemias with the most potential to impact practice.

Jorge Cortes, MD Eunice S. Wang, MD Released: March 3, 2021

Experts discuss results and implications from 3 of the key studies in acute myeloid leukemia and chronic myeloid leukemia from the virtual Hematology 2020 meeting, including magrolimab in AML, the STAMP inhibitor asciminib in CML (the ASCEMBL trial), and optimal dosing for ponatinib in CML (the OPTIC trial).

Jorge Cortes, MD Eunice S. Wang, MD Released: February 26, 2021